drug resist reduct effect drug antimicrobi anthelmint antineoplast cure diseas condit drug intend kill inhibit pathogen term equival dosag failur drug toler common term use context resist pathogen acquir resist evolv antimicrobi resist antineoplast resist challeng clinic care drive research organ resist one drug said multidrugresist even immun system organ essenc drug deliveri system albeit endogen face arm race problem extern drug deliveri
develop antibiot resist particular stem drug target specif bacteri molecul almost alway protein drug specif mutat molecul interfer negat destruct effect result antibiot resist
bacteria capabl alter enzym target antibiot also use enzym modifi antibiot thus neutralis exampl targetalt pathogen staphylococcus aureus vancomycinresist enterococci macrolideresist streptococcus exampl antibioticmodifi microb pseudomona aeruginosa aminoglycosideresist acinetobact baumannii
short lack concert effort govern pharmaceut industri togeth innat capac microb develop resist rate outpac develop new drug suggest exist strategi develop viabl longterm antimicrobi therapi ultim doom failur without altern strategi acquisit drug resist pathogen microorgan loom possibl one signific public health threat face human st centuri
resist chemic one aspect problem anoth resist physic factor temperatur pressur sound radiat magnet discuss articl found physic factor affect microbi life
introductionedit
drug toxin chemic resist consequ evolut respons pressur impos live organ individu organ vari sensit drug use greater fit may capabl surviv drug treatment drugresist trait accord inherit subsequ offspr result popul drugresist unless drug use make sexual reproduct celldivis horizont gene transfer imposs entir target popul resist drug inevit follow seen cancer tumor cell may develop resist drug use chemotherapi chemotherapi caus fibroblast near tumor produc larg amount protein wntb protein stimul growth cancer cell drugresist malaria becom resurg threat south east asia subsaharan africa drugresist strain plasmodium falciparum pose massiv problem health author leprosi shown increas resist dapson
rapid process share resist exist among singlecel organ term horizont gene transfer direct exchang gene particular biofilm state similar asexu method use fungi call parasexu exampl drugresist strain found microorgan bacteria virus parasit endo ecto plant fungi arthropod mammal bird reptil fish amphibian
domest environ drugresist strain organ may aris seem safe activ use bleach toothbrush mouthwash use antibiot disinfect deterg shampoo soap particular antibacteri soap handwash surfac spray applic deodor sunblock cosmet healthcar product insecticid dip chemic contain prepar besid harm benefici organ may intent inadvert target organ potenti develop resist
drug resist develop natur careless practic drug suppli use hasten unnecessarili center global develop
overus antibacteri clean product home may produc strain multiantibioticresist bacteria better health channel australian govern
use misus antimicrobi human medicin anim husbandri past year led relentless rise number type microorgan resist medicin lead death increas suffer disabl higher healthcar cost world health organis
death acut respiratori infect diarrhoeal diseas measl aid malaria tuberculosi account mortal infect worldwid resist firstlin drug pathogen caus diseas rang zero almost instanc resist second thirdlin agent serious compromis treatment outcom ad signific global burden resist hospitalacquir infect emerg problem antivir resist increas problem drug resist neglect parasit diseas poor margin popul global strategi contain antimicrobi resist
mechanismsedit
four main mechan microorgan exhibit resist antimicrobi
drug inactiv modif eg enzymat deactiv penicillin g penicillinresist bacteria product lactamas
alter target site eg alter pbp bind target site penicillin mrsa penicillinresist bacteria
alter metabol pathway eg sulfonamideresist bacteria requir paraaminobenzo acid paba import precursor synthesi folic acid nucleic acid bacteria inhibit sulfonamid instead like mammalian cell turn util preform folic acid
reduc drug accumul decreas drug permeabl andor increas activ efflux pump drug across cell surfac
metabol priceedit
biolog cost metabol price measur increas energi metabol requir achiev function
drug resist high metabol price pathogen concept relev bacteria endoparasit tumor cell virus equival cost genom complex
treatmentedit
chanc drug resist sometim minim use multipl drug simultan work individu mutat independ may tackl one drug time individu still kill drug mutat cannot persist use success tuberculosi howev cross resist mutat confer resist two treatment problemat
antibiot resist repres widespread problem nowaday drug design block mechan bacteri antibiot resist use exampl bacteri resist betalactam antibiot penicillin cephalosporin circumv use antibiot nafcillin suscept destruct certain betalactamas group enzym respons break betalactam betalactam bacteri resist also dealt administ betalactam antibiot drug block betalactamas clavulan acid antibiot work without get destroy bacteria first recent research recogn need new drug inhibit bacteri efflux pump caus resist multipl antibiot betalactam quinolon chloramphenicol trimethoprim send molecul antibiot bacteri cell sometim combin differ class antibiot may use synergist work togeth effect fight bacteria may resist one antibiot alon
destruct resist bacteria also achiev phage therapi specif bacteriophag virus kill bacteria use
research done use antimicrobi peptid futur possibl might replac novel antibiot
see alsoedit
antibiot resist
fecal bacteriotherapi
mass drug administr
multidrug resist
pharmacoepidemiolog
small multidrug resist protein
eleftheria terra
referencesedit
extern linksedit
burden resist diseas european nationsan eu project estim financi burden antibiot resist european hospit
merck toler resist
cosmet databas
hcmv drug resist mutat tool
combat drug resist inform articl multidrug resist
battl bug fight antibiot resist
mdripr web server predict inhibitor drug toler m tuberculosi publish chemistri central journal
cancerdr cancer drug resist databas scientif report
